tiprankstipranks
Shield Therapeutics PLC (GB:STX)
LSE:STX
UK Market
STX
Shield Therapeutics
RESEARCH TOOLSreports

Shield Therapeutics (STX) Cash flow

42 Followers

Shield Therapeutics Cash Flow

GB:STX's free cash flow for Q4 2025 was £-13.02M. For the 2025 fiscal year, GB:STX's free cash flow was decreased by £-1.80M and operating cash flow was £-13.00M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Jun 22
Operating Cash Flow
£ -8.81M£ -7.01M£ -37.13M£ -18.25M£ -16.74M
Investing Cash Flow
£ -306.29K£ -1.89M£ -2.43M£ -1.70M£ -2.05M
Financing Cash Flow
£ 13.75M£ 4.21M£ 49.66M£ 7.71M£ 27.58M
End Cash Position
£ 11.63M£ 5.61M£ 13.95M£ 2.82M£ 12.12M
Free Cash Flow
£ -8.83M£ -7.03M£ -40.07M£ -20.14M£ -18.80M
Currency in GBP

Shield Therapeutics Cash Flow